The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD ; volume:15 ; number:1 ; day:21 ; month:7 ; year:2024 ; pages:1-18 ; date:12.2024
Nature Communications ; 15, Heft 1 (21.7.2024), 1-18, 12.2024
- Creator
-
Ghosh, Sayan
Sharma, Ruchi
Bammidi, Sridhar
Koontz, Victoria
Nemani, Mihir
Yazdankhah, Meysam
Kedziora, Katarzyna M.
Stolz, Donna Beer
Wallace, Callen T.
Yu-Wei, Cheng
Franks, Jonathan
Bose, Devika
Shang, Peng
Ambrosino, Helena M.
Dutton, James R.
Geng, Zhaohui
Montford, Jair
Ryu, Jiwon
Rajasundaram, Dhivyaa
Hose, Stacey
Sahel, José-Alain
Puertollano, Rosa
Finkel, Toren
Zigler, J. Samuel
Sergeev, Yuri
Watkins, Simon C.
Goetzman, Eric S.
Ferrington, Deborah A.
Flores-Bellver, Miguel
Kaarniranta, Kai
Sodhi, Akrit
Bharti, Kapil
Handa, James T.
Sinha, Debasish
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-50500-z
- URN
-
urn:nbn:de:101:1-2410250910089.499040944456
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ghosh, Sayan
- Sharma, Ruchi
- Bammidi, Sridhar
- Koontz, Victoria
- Nemani, Mihir
- Yazdankhah, Meysam
- Kedziora, Katarzyna M.
- Stolz, Donna Beer
- Wallace, Callen T.
- Yu-Wei, Cheng
- Franks, Jonathan
- Bose, Devika
- Shang, Peng
- Ambrosino, Helena M.
- Dutton, James R.
- Geng, Zhaohui
- Montford, Jair
- Ryu, Jiwon
- Rajasundaram, Dhivyaa
- Hose, Stacey
- Sahel, José-Alain
- Puertollano, Rosa
- Finkel, Toren
- Zigler, J. Samuel
- Sergeev, Yuri
- Watkins, Simon C.
- Goetzman, Eric S.
- Ferrington, Deborah A.
- Flores-Bellver, Miguel
- Kaarniranta, Kai
- Sodhi, Akrit
- Bharti, Kapil
- Handa, James T.
- Sinha, Debasish
- SpringerLink (Online service)
Other Objects (12)
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Gains in the current understanding of managing neovascular AMD with brolucizumab
Cataract surgery in neovascular AMD: impact on visual acuity and disease activity
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD
Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Purinergic signalling pathway: therapeutic target in ovarian cancer
PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration
Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway
The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Gains in the current understanding of managing neovascular AMD with brolucizumab
Cataract surgery in neovascular AMD: impact on visual acuity and disease activity
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD
Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Purinergic signalling pathway: therapeutic target in ovarian cancer
PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration
Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway
The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Gains in the current understanding of managing neovascular AMD with brolucizumab
Cataract surgery in neovascular AMD: impact on visual acuity and disease activity
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD
Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Purinergic signalling pathway: therapeutic target in ovarian cancer
PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration
Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway